ARCHOS announces that its Medical Devices Venture subsidiaries, Dextrain and Poladerme, have been awarded the BPI Deep tech label and the French Tech Emergence grant (BFTE) in May 2022 and November 2022, respectively, for an amount of 90,000 euros to finance their disruptive innovation projects resulting from academic research.
The BFTE is a Bpifrance program that finances disruptive innovation projects with a high technological content qualified as deeptech
Dextrain, a start-up that grew out of Erganeo, combines its manual dexterity technology with Machine Learning to offer a unique solution for the rehabilitation and prediction of neurological diseases for millions of individuals.